Akiko Tamura
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Akiko Tamura has a total of 22 co-authors. Here are the top co-authors by number of shared publications:
Norihiro Shigematsu
Research Institute, FANCL Co. , Yokohama
3 shared publicationsTakuya Shiomi
3 shared publications- Fusao Tomita
Laboratory of Applied Microbiology, Department of Molecular Bioscience, Division of Applied Bioscience, Graduate School of Agriculture, Hokkaido University, Sapporo, Japan
2 shared publications Hiroshi Hara
Division of Applied Bioscience , Graduate School of Agriculture, Hokkaido University , Sapporo
2 shared publications- Norihiro Shigematsu
Biosci. Textile Technol., Shinshu University, Ueda, Nagano, Japan
2 shared publications Noriko Tamaki
2 shared publications
Latest Publications
- 1 October 2006
- Published by Taylor & Francis in Archives of Animal Nutrition
- Vol. 60 (5) , 358-364
Different effects of difructose anhydride III and inulin-type fructans on caecal microbiota in rats
The effects of different kinds of inulin-type fructans on caecal microbiota were evaluated in rats. Four groups of male Wistar rats were fed either a control diet, or diets containing 5% inulin, 5% fructooligosaccharides (FOS), or 5% difructose anhydride III (DFAIII) for two weeks. In the DFAIII group, caecal propionate, butyrate, counts of bifidobacteria, and total anaerobes were lower than in the inulin group, while caecal propionate, succinate, counts of bifidobacteria, and total anaerobes were lower than in the FOS group. Compared to controls, in the DFAIII group the counts of clostridia in caecum were increased by 3 log units. However, this change was statistically not significant. There were no differences between inulin and FOS groups for the pool of short chain fatty acids in caecum and bacterial counts. Results indicate that DFAIII has different effects on caecal microbiota compared to inulin and FOS and that these differences are most likely due to the α(3→2) bonds in DFAIII.
- 1 October 2006
- Published by Taylor & Francis in Archives of Animal Nutrition
- Vol. 60 (5) , 358-364
Different effects of difructose anhydride III and inulin-type fructans on caecal microbiota in rats
The effects of different kinds of inulin-type fructans on caecal microbiota were evaluated in rats. Four groups of male Wistar rats were fed either a control diet, or diets containing 5% inulin, 5% fructooligosaccharides (FOS), or 5% difructose anhydride III (DFAIII) for two weeks. In the DFAIII group, caecal propionate, butyrate, counts of bifidobacteria, and total anaerobes were lower than in the inulin group, while caecal propionate, succinate, counts of bifidobacteria, and total anaerobes were lower than in the FOS group. Compared to controls, in the DFAIII group the counts of clostridia in caecum were increased by 3 log units. However, this change was statistically not significant. There were no differences between inulin and FOS groups for the pool of short chain fatty acids in caecum and bacterial counts. Results indicate that DFAIII has different effects on caecal microbiota compared to inulin and FOS and that these differences are most likely due to the α(3→2) bonds in DFAIII.
- 1 January 2004
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 68 (9) , 1882-1887
Comparative Effect of Repeated Ingestion of Difructose Anhydride III and Palatinose on the Induction of Gastrointestinal Symptoms in Humans
We evaluated the safety and change in fermentability from repeated ingestion of difructose anhydride III (DFAIII) in humans. A randomized controlled single-blind crossover study with thirteen subjects was conducted. Each subject ingested 5 g of DFAIII or palatinose daily for 12 days, before and after which the subject was loaded with 10 g of DFAIII and had breath hydrogen measured from 0 to 9 h (DL test) to evaluate the fermentability of DFAIII. The defecation frequency and abdominal symptom score were the same between each ingestion period. Moreover, DFAIII ingestion had no influence on blood test results. Only the breath hydrogen excretion in post-DFAIII ingestion was slightly higher at h 8 than the pre-ingestion. Consequently, repeated ingestion of DFAIII for 12 days was as safe as palatinose ingestion, especially with respect to abdominal symptoms and blood test results, and its high resistance to enterobacterial fermentation in humans was not impaired.
- 1 January 2004
- Published by Oxford University Press (OUP) in Bioscience, Biotechnology, and Biochemistry
- Vol. 68 (9) , 1882-1887
Comparative Effect of Repeated Ingestion of Difructose Anhydride III and Palatinose on the Induction of Gastrointestinal Symptoms in Humans
We evaluated the safety and change in fermentability from repeated ingestion of difructose anhydride III (DFAIII) in humans. A randomized controlled single-blind crossover study with thirteen subjects was conducted. Each subject ingested 5 g of DFAIII or palatinose daily for 12 days, before and after which the subject was loaded with 10 g of DFAIII and had breath hydrogen measured from 0 to 9 h (DL test) to evaluate the fermentability of DFAIII. The defecation frequency and abdominal symptom score were the same between each ingestion period. Moreover, DFAIII ingestion had no influence on blood test results. Only the breath hydrogen excretion in post-DFAIII ingestion was slightly higher at h 8 than the pre-ingestion. Consequently, repeated ingestion of DFAIII for 12 days was as safe as palatinose ingestion, especially with respect to abdominal symptoms and blood test results, and its high resistance to enterobacterial fermentation in humans was not impaired.
- 1 January 2004
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 98 (4) , 244-250
The Effects of Di-D-Fructofuranose-1,2′:2,3′-Dianhydride (DFA III) Administration on Human Intestinal Microbiota
- 1 January 2004
- Published by Elsevier in Journal of Bioscience and Bioengineering
- Vol. 98 (4) , 244-250
The Effects of Di-D-Fructofuranose-1,2′:2,3′-Dianhydride (DFA III) Administration on Human Intestinal Microbiota
- Open Access
- 1 January 2003
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 49 (6) , 422-427
Evidence Suggesting That Difructose Anhydride III Is an Indigestible and Low Fermentable Sugar during the Early Stages after Ingestion in Humans
We investigated the influences of difructose anhydride III (DFAIII), a novel commercially available disaccharide, on sugar metabolism, breath hydrogen and serum acetate in the early stages after ingestion to determine whether DFAIII is an indigestible sugar and to what degree it is fermentable in humans. This study was designed as a randomized controlled single-blind crossover test with 9 healthy subjects, who drink a 200mL water solution containing 10g of DFAIII, lactulose or sucrose following overnight fasting. Blood samples (for analysis of glucose, fructose, insulin, triacylglycerol, free fatty acids, and acetate) were collected at 0, 0.5, 1, 2, 4, 8h after the ingestion and breath samples (for analysis of hydrogen and methane gases) were collected at 1h intervals until 8h after the ingestion. We also interviewed each subject hourly about the incidence and severity of specific abdominal complaints and other symptoms. The results revealed that ingestion of 10g of DFAIII did not change the serum levels of glucose, fructose, and insulin, similarly to the case with lactulose, and no increase in breath hydrogen excretion was comparable to the case with sucrose. The incidence of specific abdominal symptoms tended to be lower after DFAIII ingestion than after lactulose ingestion. It thus turned out that DFAIII was indigestible and low fermentable in the early stages after ingestion.
- 1 January 2003
- Published by Center for Academic Publications Japan in Journal of Nutritional Science and Vitaminology
- Vol. 49 (6) , 422-427
Open AccessEvidence Suggesting That Difructose Anhydride III Is an Indigestible and Low Fermentable Sugar during the Early Stages after Ingestion in Humans
We investigated the influences of difructose anhydride III (DFAIII), a novel commercially available disaccharide, on sugar metabolism, breath hydrogen and serum acetate in the early stages after ingestion to determine whether DFAIII is an indigestible sugar and to what degree it is fermentable in humans. This study was designed as a randomized controlled single-blind crossover test with 9 healthy subjects, who drink a 200mL water solution containing 10g of DFAIII, lactulose or sucrose following overnight fasting. Blood samples (for analysis of glucose, fructose, insulin, triacylglycerol, free fatty acids, and acetate) were collected at 0, 0.5, 1, 2, 4, 8h after the ingestion and breath samples (for analysis of hydrogen and methane gases) were collected at 1h intervals until 8h after the ingestion. We also interviewed each subject hourly about the incidence and severity of specific abdominal complaints and other symptoms. The results revealed that ingestion of 10g of DFAIII did not change the serum levels of glucose, fructose, and insulin, similarly to the case with lactulose, and no increase in breath hydrogen excretion was comparable to the case with sucrose. The incidence of specific abdominal symptoms tended to be lower after DFAIII ingestion than after lactulose ingestion. It thus turned out that DFAIII was indigestible and low fermentable in the early stages after ingestion.
- Open Access
- 1 January 2003
- Published by Japan Society for Bioscience, Biotechnology, and Agrochemistry in Journal of the agricultural chemical society of Japan
- Vol. 77 (10) , 1004-1006
Effects of calcium concentration and pH on difructose anhydride III enhance calcium absorption from rat small and large intestinal epithelium in vitro
- 1 January 2003
- Published by Japan Society for Bioscience, Biotechnology, and Agrochemistry in Journal of the agricultural chemical society of Japan
- Vol. 77 (10) , 1004-1006
Open AccessEffects of calcium concentration and pH on difructose anhydride III enhance calcium absorption from rat small and large intestinal epithelium in vitro